Mco Hospital Aids Private Limited

Polyglactin 910 Rapid is a synthetic, absorbable, braided suture designed for situations requiring short-term wound support. Composed of a copolymer made from 90% glycolide and 10% L-lactide, it undergoes a unique irradiation process that accelerates its absorption rate compared to standard Polyglactin 910 sutures.

Key Characteristics:

• Rapid Absorption: Designed for quick absorption, providing wound support for approximately 7 to 10 days, with complete absorption typically occurring within 42 days.
• Tensile Strength: Retains about 50% of its initial tensile strength at 5 days post-implantation and loses all tensile strength by 10 to 14 days.
• Composition: Made from a copolymer of 90% glycolide and 10% L-lactide, coated with a copolymer of glycolide and lactide (Polyglactin 370) and calcium stearate, enhancing its handling properties and knot security.
• Minimal Tissue Reaction: Elicits only a mild tissue response during absorption, reducing the risk of inflammation and promoting smoother healing.
• Availability: Offered in both dyed (violet) and undyed forms, and in various sizes to accommodate different surgical needs.

Common Applications:

Polyglactin 910 Rapid sutures are particularly suited for procedures where short-term wound support is sufficient, such as:

• Superficial Soft Tissue Approximation: Ideal for skin closures, including episiotomies, circumcisions, and closure of oral mucosa.
• Pediatric Surgery: Beneficial in procedures involving children, where rapid healing is anticipated.
• Ophthalmic Procedures: Suitable for conjunctival suturing and other eye-related surgeries.

Advantages:

• Excellent Handling and Knotting Characteristics: The braided and coated structure ensures smooth tissue passage, easy knotting, and reliable knot security.
• Predictable Absorption: Absorbed through hydrolysis, providing a reliable and consistent absorption profile.
• Reduced Need for Suture Removal: As an absorbable suture, it eliminates the necessity for suture removal, enhancing patient comfort and compliance.

Considerations:

• Limited Duration of Wound Support: Not suitable for tissues requiring extended support beyond 10 days.
• Avoid in High-Tension Areas: Not recommended for use in cardiovascular or neurological tissues, or in areas subjected to significant mechanical stress.

Polyglactin 910 Rapid is a synthetic, absorbable, braided suture designed for situations requiring short-term wound support. Composed of a copolymer made from 90% glycolide and 10% L-lactide, it undergoes a unique irradiation process that accelerates its absorption rate compared to standard Polyglactin 910 sutures.

Key Characteristics:

• Rapid Absorption: Designed for quick absorption, providing wound support for approximately 7 to 10 days, with complete absorption typically occurring within 42 days.
• Tensile Strength: Retains about 50% of its initial tensile strength at 5 days post-implantation and loses all tensile strength by 10 to 14 days.
• Composition: Made from a copolymer of 90% glycolide and 10% L-lactide, coated with a copolymer of glycolide and lactide (Polyglactin 370) and calcium stearate, enhancing its handling properties and knot security.
• Minimal Tissue Reaction: Elicits only a mild tissue response during absorption, reducing the risk of inflammation and promoting smoother healing.
• Availability: Offered in both dyed (violet) and undyed forms, and in various sizes to accommodate different surgical needs.

Common Applications:

Polyglactin 910 Rapid sutures are particularly suited for procedures where short-term wound support is sufficient, such as:

• Superficial Soft Tissue Approximation: Ideal for skin closures, including episiotomies, circumcisions, and closure of oral mucosa.
• Pediatric Surgery: Beneficial in procedures involving children, where rapid healing is anticipated.
• Ophthalmic Procedures: Suitable for conjunctival suturing and other eye-related surgeries.

Advantages:

• Excellent Handling and Knotting Characteristics: The braided and coated structure ensures smooth tissue passage, easy knotting, and reliable knot security.
• Predictable Absorption: Absorbed through hydrolysis, providing a reliable and consistent absorption profile.
• Reduced Need for Suture Removal: As an absorbable suture, it eliminates the necessity for suture removal, enhancing patient comfort and compliance.

Considerations:

• Limited Duration of Wound Support: Not suitable for tissues requiring extended support beyond 10 days.
• Avoid in High-Tension Areas: Not recommended for use in cardiovascular or neurological tissues, or in areas subjected to significant mechanical stress.

Relyon Polyglactin 910 is a synthetic, absorbable, sterile surgical suture composed of a copolymer made from 90% glycolide and 10% L-lactide.  

This suture is typically braided and coated to enhance its handling properties and reduce tissue drag during passage. The coating often consists of a copolymer of poly (glycolide-co-L-lactide) and calcium stearate, which facilitates smooth passage through tissues and reliable knot security.

Polyglactin 910 sutures are available in both dyed (violet) and undyed forms. The violet dye, approved by the FDA, aids in visibility during surgical procedures.

In terms of tensile strength, Polyglactin 910 retains approximately 75% of its strength at 14 days post-implantation. Absorption occurs through hydrolysis, with complete absorption typically between 56 and 70 days.

This suture is indicated for use in general soft tissue approximation and/or ligation, including in ophthalmic procedures. However, it is not recommended for use in cardiovascular or neurological tissues.

Polyglactin 910 sutures are available in various sizes, ranging from USP 3-0 to 1, and can be equipped with different needle types, including taper point, cutting edge, and reverse cutting needles, to suit diverse surgical requirements.

Overall, Polyglactin 910 sutures are valued for their predictable absorption profile, excellent handling characteristics, and minimal tissue reaction, making them a preferred choice in various surgical procedures.

Relyon Polyglactin 910 is a synthetic, absorbable, sterile surgical suture composed of a copolymer made from 90% glycolide and 10% L-lactide.  

This suture is typically braided and coated to enhance its handling properties and reduce tissue drag during passage. The coating often consists of a copolymer of poly (glycolide-co-L-lactide) and calcium stearate, which facilitates smooth passage through tissues and reliable knot security.

Polyglactin 910 sutures are available in both dyed (violet) and undyed forms. The violet dye, approved by the FDA, aids in visibility during surgical procedures.

In terms of tensile strength, Polyglactin 910 retains approximately 75% of its strength at 14 days post-implantation. Absorption occurs through hydrolysis, with complete absorption typically between 56 and 70 days.

This suture is indicated for use in general soft tissue approximation and/or ligation, including in ophthalmic procedures. However, it is not recommended for use in cardiovascular or neurological tissues.

Polyglactin 910 sutures are available in various sizes, ranging from USP 3-0 to 1, and can be equipped with different needle types, including taper point, cutting edge, and reverse cutting needles, to suit diverse surgical requirements.

Overall, Polyglactin 910 sutures are valued for their predictable absorption profile, excellent handling characteristics, and minimal tissue reaction, making them a preferred choice in various surgical procedures.

Loop sutures, particularly in the context of flexor tendon repairs, offer several advantages over traditional single-stranded sutures:

1. Enhanced Strength with Fewer Passes: Looped sutures can achieve multiple strands across the repair site with fewer needle passes, reducing technical complexity while maintaining or enhancing the repair's strength.
2. Improved Biomechanical Performance: Studies have shown that looped sutures can provide superior biomechanical properties compared to equivalent repairs using single-stranded sutures, contributing to more robust and reliable repairs.
3. Efficient Wound Closure: In procedures like abdominal wall closures, looped sutures, especially when combined with techniques like the "small bites" method, can offer better biomechanical properties, favorable collagen synthesis along the incision, and economic benefits due to significant savings in time and material.

It's important to note that while looped sutures offer these advantages, the choice of suture technique should be tailored to the specific clinical scenario, considering factors such as tissue type, tension, and the desired healing outcome.

Relyon Polyglactin 910 is a synthetic, absorbable, sterile surgical suture composed of a copolymer made from 90% glycolide and 10% L-lactide.  

This suture is typically braided and coated to enhance its handling properties and reduce tissue drag during passage. The coating often consists of a copolymer of poly (glycolide-co-L-lactide) and calcium stearate, which facilitates smooth passage through tissues and reliable knot security.

Polyglactin 910 sutures are available in both dyed (violet) and undyed forms. The violet dye, approved by the FDA, aids in visibility during surgical procedures.

In terms of tensile strength, Polyglactin 910 retains approximately 75% of its strength at 14 days post-implantation. Absorption occurs through hydrolysis, with complete absorption typically between 56 and 70 days.

This suture is indicated for use in general soft tissue approximation and/or ligation, including in ophthalmic procedures. However, it is not recommended for use in cardiovascular or neurological tissues.

Polyglactin 910 sutures are available in various sizes, ranging from USP 4-0 to 1, and can be equipped with different needle types, including taper point, cutting edge, and reverse cutting needles, to suit diverse surgical requirements.

Overall, Polyglactin 910 sutures are valued for their predictable absorption profile, excellent handling characteristics, and minimal tissue reaction, making them a preferred choice in various surgical procedures.

Polyglactin 910 Rapid is a synthetic, absorbable, braided suture designed for situations requiring short-term wound support. Composed of a copolymer made from 90% glycolide and 10% L-lactide, it undergoes a unique irradiation process that accelerates its absorption rate compared to standard Polyglactin 910 sutures.

Key Characteristics:

• Rapid Absorption: Designed for quick absorption, providing wound support for approximately 7 to 10 days, with complete absorption typically occurring within 42 days.
• Tensile Strength: Retains about 50% of its initial tensile strength at 5 days post-implantation and loses all tensile strength by 10 to 14 days.
• Composition: Made from a copolymer of 90% glycolide and 10% L-lactide, coated with a copolymer of glycolide and lactide (Polyglactin 370) and calcium stearate, enhancing its handling properties and knot security.
• Minimal Tissue Reaction: Elicits only a mild tissue response during absorption, reducing the risk of inflammation and promoting smoother healing.
• Availability: Offered in both dyed (violet) and undyed forms, and in various sizes to accommodate different surgical needs.

Common Applications:

Polyglactin 910 Rapid sutures are particularly suited for procedures where short-term wound support is sufficient, such as:

• Superficial Soft Tissue Approximation: Ideal for skin closures, including episiotomies, circumcisions, and closure of oral mucosa.
• Pediatric Surgery: Beneficial in procedures involving children, where rapid healing is anticipated.
• Ophthalmic Procedures: Suitable for conjunctival suturing and other eye-related surgeries.

Advantages:

• Excellent Handling and Knotting Characteristics: The braided and coated structure ensures smooth tissue passage, easy knotting, and reliable knot security.
• Predictable Absorption: Absorbed through hydrolysis, providing a reliable and consistent absorption profile.
• Reduced Need for Suture Removal: As an absorbable suture, it eliminates the necessity for suture removal, enhancing patient comfort and compliance.

Considerations:

• Limited Duration of Wound Support: Not suitable for tissues requiring extended support beyond 10 days.
• Avoid in High-Tension Areas: Not recommended for use in cardiovascular or neurological tissues, or in areas subjected to significant mechanical stress.

Relyon Polyglactin 910 is a synthetic, absorbable, sterile surgical suture composed of a copolymer made from 90% glycolide and 10% L-lactide.  

This suture is typically braided and coated to enhance its handling properties and reduce tissue drag during passage. The coating often consists of a copolymer of poly (glycolide-co-L-lactide) and calcium stearate, which facilitates smooth passage through tissues and reliable knot security.

Polyglactin 910 sutures are available in both dyed (violet) and undyed forms. The violet dye, approved by the FDA, aids in visibility during surgical procedures.

In terms of tensile strength, Polyglactin 910 retains approximately 75% of its strength at 14 days post-implantation. Absorption occurs through hydrolysis, with complete absorption typically between 56 and 70 days.

This suture is indicated for use in general soft tissue approximation and/or ligation, including in ophthalmic procedures. However, it is not recommended for use in cardiovascular or neurological tissues.

Polyglactin 910 sutures are available in various sizes, ranging from USP 4-0 to 1, and can be equipped with different needle types, including taper point, cutting edge, and reverse cutting needles, to suit diverse surgical requirements.

Overall, Polyglactin 910 sutures are valued for their predictable absorption profile, excellent handling characteristics, and minimal tissue reaction, making them a preferred choice in various surgical procedures.

Relyon Polyglactin 910 is a synthetic, absorbable, sterile surgical suture composed of a copolymer made from 90% glycolide and 10% L-lactide.  

This suture is typically braided and coated to enhance its handling properties and reduce tissue drag during passage. The coating often consists of a copolymer of poly (glycolide-co-L-lactide) and calcium stearate, which facilitates smooth passage through tissues and reliable knot security.

Polyglactin 910 sutures are available in both dyed (violet) and undyed forms. The violet dye, approved by the FDA, aids in visibility during surgical procedures.

In terms of tensile strength, Polyglactin 910 retains approximately 75% of its strength at 14 days post-implantation. Absorption occurs through hydrolysis, with complete absorption typically between 56 and 70 days.

This suture is indicated for use in general soft tissue approximation and/or ligation, including in ophthalmic procedures. However, it is not recommended for use in cardiovascular or neurological tissues.

Polyglactin 910 sutures are available in various sizes, ranging from USP 4-0 to 1, and can be equipped with different needle types, including taper point, cutting edge, and reverse cutting needles, to suit diverse surgical requirements.

Overall, Polyglactin 910 sutures are valued for their predictable absorption profile, excellent handling characteristics, and minimal tissue reaction, making them a preferred choice in various surgical procedures.

Relyon Polyglactin 910 is a synthetic, absorbable, sterile surgical suture composed of a copolymer made from 90% glycolide and 10% L-lactide.  

This suture is typically braided and coated to enhance its handling properties and reduce tissue drag during passage. The coating often consists of a copolymer of poly (glycolide-co-L-lactide) and calcium stearate, which facilitates smooth passage through tissues and reliable knot security.

Polyglactin 910 sutures are available in both dyed (violet) and undyed forms. The violet dye, approved by the FDA, aids in visibility during surgical procedures.

In terms of tensile strength, Polyglactin 910 retains approximately 75% of its strength at 14 days post-implantation. Absorption occurs through hydrolysis, with complete absorption typically between 56 and 70 days.

This suture is indicated for use in general soft tissue approximation and/or ligation, including in ophthalmic procedures. However, it is not recommended for use in cardiovascular or neurological tissues.

Polyglactin 910 sutures are available in various sizes, ranging from USP 4-0 to 1, and can be equipped with different needle types, including taper point, cutting edge, and reverse cutting needles, to suit diverse surgical requirements.

Overall, Polyglactin 910 sutures are valued for their predictable absorption profile, excellent handling characteristics, and minimal tissue reaction, making them a preferred choice in various surgical procedures.

Relyon Polyglactin 910 is a synthetic, absorbable, sterile surgical suture composed of a copolymer made from 90% glycolide and 10% L-lactide.  

This suture is typically braided and coated to enhance its handling properties and reduce tissue drag during passage. The coating often consists of a copolymer of poly (glycolide-co-L-lactide) and calcium stearate, which facilitates smooth passage through tissues and reliable knot security.

Polyglactin 910 sutures are available in both dyed (violet) and undyed forms. The violet dye, approved by the FDA, aids in visibility during surgical procedures.

In terms of tensile strength, Polyglactin 910 retains approximately 75% of its strength at 14 days post-implantation. Absorption occurs through hydrolysis, with complete absorption typically between 56 and 70 days.

This suture is indicated for use in general soft tissue approximation and/or ligation, including in ophthalmic procedures. However, it is not recommended for use in cardiovascular or neurological tissues.

Polyglactin 910 sutures are available in various sizes, ranging from USP 4-0 to 1, and can be equipped with different needle types, including taper point, cutting edge, and reverse cutting needles, to suit diverse surgical requirements.

Overall, Polyglactin 910 sutures are valued for their predictable absorption profile, excellent handling characteristics, and minimal tissue reaction, making them a preferred choice in various surgical procedures.